PerkinElmer is slimming down to focus solely on diagnostics and life sciences research, selling off its other businesses in a deal that will hand it $2.3 billion in cash. The funding is expected to ...

A new hub designed to bring customers, applications, and real-time process insight together to turn analytical science ...

A month has gone by since the last earnings report for PerkinElmer (PKI). Shares have lost about 11.6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

PerkinElmer is acquiring Covaris, which manufactures applications and solutions for life science companies, as part of an effort to expand its life sciences portfolio. The biotech announced Monday ...

After going through a company split earlier this year, PerkinElmer has found a new dance partner—a match orchestrated by its corporate owner, the private equity firm New Mountain Capital. New Mountain ...

PerkinElmer said today it agreed to acquire BioLegend, a provider of life science antibodies and reagents, for approximately $5.25 billion in cash and stock—the largest acquisition in the buyer’s ...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $500.0 million ...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) today announced it has entered into an agreement to acquire BioLegend, a leading, global provider of life science ...

PerkinElmer's shares have risen more than 47% in 2020, so why isn't everyone talking about this fast-rising testing company? PerkinElmer sells high-end laboratory equipment like mass spectrometers and ...

PerkinElmer, Inc. PKI recently completed its buyout of BioLegend for a total consideration of approximately $5.25 billion. The latest buyout, which is historically the largest for the company, is ...